Login to Your Account

Aceon Gets Broader Label, Paves Sales Path For Ranexa

By Aaron Lorenzo

Thursday, August 25, 2005
The FDA approved a wider label for Aceon (perindopril erbumine), a cardiovascular drug marketed in part by CV Therapeutics Inc. through a partnership that has laid the groundwork for eventual sales of another of its drugs, Ranexa. (BioWorld Today)

To continue reading subscribe now to BioWorld Today

Learn More about BioWorld Today

Already a subscriber? Sign In or Buy now to activate your subscription